SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO)

Q: What does CUSIP 800677106 represent in this 13F holders report?

CUSIP 800677106 is the security identifier for SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share used to aggregate holder disclosures.

Q: How many institutions held SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share in Q1 2018?

205 institutional investors reported SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share for Q1 2018. Use the holders table for investor-level position and value details.

CUSIP: 800677106

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock, $0.01 par value per share
Shares outstanding: 414,359,662
Total 13F shares: 57,191,865
Share change: +1,627,718
Total reported value: $1,086,683,045
Put/Call ratio: 125%
Price per share: $19.00
Number of holders: 205
Value change: +$32,050,241
Number of buys: 105
Number of sells: 88

Quarterly Holders Quick Answers

What is CUSIP 800677106?
CUSIP 800677106 identifies SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 800677106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	1.7%	6,871,509	$112,691,000	—	31 Dec 2017	13F
FMR LLC	13F	Company	1.3%	5,355,421	$87,829,000	—	31 Dec 2017	13F
WASATCH ADVISORS LP	13F	Company	1.1%	4,698,511	$77,056,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	1.1%	4,479,969	$73,472,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	0.96%	3,979,593	$65,268,000	—	31 Dec 2017	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.58%	2,400,000	$39,360,000	—	31 Dec 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	0.51%	2,113,376	$34,659,000	—	31 Dec 2017	13F
Casdin Capital, LLC	13F	Company	0.34%	1,400,000	$22,960,000	—	31 Dec 2017	13F
Invesco Ltd.	13F	Company	0.33%	1,376,028	$22,567,000	—	31 Dec 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.33%	1,364,295	$22,375,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.26%	1,060,932	$17,400,000	—	31 Dec 2017	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.23%	966,128	$15,844,000	—	31 Dec 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.23%	946,128	$15,516,000	—	31 Dec 2017	13F
Alexandria Capital, LLC	13F	Company	0.22%	925,527	$15,179,000	—	31 Dec 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	911,512	$14,948,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.21%	883,382	$14,487,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	840,104	$13,777,000	—	31 Dec 2017	13F
NEXTHERA CAPITAL LP	13F	Company	0.17%	708,544	$11,620,000	—	31 Dec 2017	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.16%	665,890	$10,921,000	—	31 Dec 2017	13F
CREDIT SUISSE AG/	13F	Company	0.15%	641,805	$10,525,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.14%	593,562	$9,735,000	—	31 Dec 2017	13F
Opaleye Management Inc.	13F	Company	0.14%	580,000	$9,512,000	—	31 Dec 2017	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.12%	477,726	$7,835,000	—	31 Dec 2017	13F
PDT Partners, LLC	13F	Company	0.11%	471,649	$7,735,000	—	31 Dec 2017	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.11%	469,099	$7,693,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	433,717	$7,113,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.1%	422,397	$6,928,000	—	31 Dec 2017	13F
Cormorant Asset Management, LP	13F	Company	0.1%	400,000	$6,560,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.09%	392,713	$6,440,000	—	31 Dec 2017	13F
ALTRINSIC GLOBAL ADVISORS LLC	13F	Company	0.08%	350,000	$5,740,000	—	31 Dec 2017	13F
ROYCE & ASSOCIATES LP	13F	Company	0.08%	330,965	$5,428,000	—	31 Dec 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	321,648	$5,275,000	—	31 Dec 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	311,330	$5,106,000	—	31 Dec 2017	13F
FEDERATED HERMES, INC.	13F	Company	0.07%	292,433	$4,796,000	—	31 Dec 2017	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.07%	290,479	$4,764,000	—	31 Dec 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	276,791	$4,539,000	—	31 Dec 2017	13F
Rhenman & Partners Asset Management AB	13F	Company	0.06%	255,793	$4,195,000	—	31 Dec 2017	13F
GROUP ONE TRADING LLC	13F	Company	0.06%	241,729	$3,964,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	237,351	$3,890,000	—	31 Dec 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.06%	230,252	$3,776,000	—	31 Dec 2017	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.05%	207,433	$3,402,000	—	31 Dec 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	194,719	$3,193,000	—	31 Dec 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	190,583	$3,126,000	—	31 Dec 2017	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.04%	185,000	$3,034,000	—	31 Dec 2017	13F
CITIGROUP INC	13F	Company	0.04%	158,597	$2,600,000	—	31 Dec 2017	13F
Granahan Investment Management, LLC	13F	Company	0.04%	155,704	$2,554,000	—	31 Dec 2017	13F
Iguana Healthcare Management, LLC	13F	Company	0.04%	150,000	$2,460,000	—	31 Dec 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	149,235	$2,447,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.03%	142,460	$2,336,000	—	31 Dec 2017	13F
QS Investors, LLC	13F	Company	0.03%	141,421	$2,319,000	—	31 Dec 2017	13F

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) as of Q1 2018

As of 31 Mar 2018, SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) was held by 205 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,191,865 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, WASATCH ADVISORS INC, ADAGE CAPITAL PARTNERS GP, L.L.C., CREDIT SUISSE AG/, BAKER BROS. ADVISORS LP, Casdin Capital, LLC, and MORGAN STANLEY. This page lists 205 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

167

Q1 2018 holders

205

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.